Literature DB >> 15315529

Cerebrospinal fluid glutamate levels in chronic migraine.

M F P Peres1, E Zukerman, C A Senne Soares, E O Alonso, B F C Santos, M H W Faulhaber.   

Abstract

Both preclinical and clinical data link glutamate to the migraine pathophisiology. Altered plasma, platelets and cerebrospinal (CSF) glutamate levels have been reported in migraine patients. Chronic migraine is comorbid with several conditions. It has been recently shown chronic migraine comorbidity with fibromyalgia. The objective of this study was to study cerebrospinal fluid glutamate levels in chronic migraine patients with and without fibromyalgia. We studied 20 chronic migraine patients, with and without fibromyalgia, compared to age-sex matched controls. CSF glutamate levels were measured by HPLC. CSF glutamate demonstrated significantly higher levels in patients with fibromyalgia compared to those without fibromyalgia. Patients overall had higher CSF glutamate levels than controls. Mean pain score correlated with glutamate levels in chronic migraine patients. Tender points, the hallmark of fibromyalgia, can be considered as pressure allodynia, and is probably mediated by central sensitization, with increase in CSF glutamate levels. We postulate chronic migraine patients with fibromyalgia, in addition to have more disabling headaches, suffer from a more severe central sensitization process. This subtype of patients may respond to medications modulating glutamate receptors. Headache intensity correlate with glutamate levels in chronic migraine patients. Copyright 2004 Blackwell Publishing Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315529     DOI: 10.1111/j.1468-2982.2004.00750.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  35 in total

1.  [Chronic cluster headache : how much does treatment cost?].

Authors:  T P Jürgens; A May
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

Review 2.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 3.  Sensitization, glutamate, and the link between migraine and fibromyalgia.

Authors:  Paola Sarchielli; Massimiliano Di Filippo; Katiuscia Nardi; Paolo Calabresi
Journal:  Curr Pain Headache Rep       Date:  2007-10

4.  Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.

Authors:  Larissa Bittencourt da Silva; Ali Karshenas; Flemming Winther Bach; Sten Rasmussen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Pain Res Manag       Date:  2014 May-Jun       Impact factor: 3.037

Review 5.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

Review 6.  Could Dietary Glutamate Play a Role in Psychiatric Distress?

Authors:  A Zarina Kraal; Nicole R Arvanitis; Andrew P Jaeger; Vicki L Ellingrod
Journal:  Neuropsychobiology       Date:  2019-01-30       Impact factor: 2.328

Review 7.  [Update on trigeminal autonomic cephalalgia].

Authors:  C Gaul; D Holle; A May
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

8.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

Review 9.  Neuromodulators for the treatment of headache disorders and fibromyalgia.

Authors:  Abouch V Krymchantowski; Juline Bryson; Richard B Lipton; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2008-10

Review 10.  Fibromyalgia: an update and immunological aspects.

Authors:  Eduardo S Paiva; Evelin Diana Goldenberg Mariano da Costa; Morton Scheinberg
Journal:  Curr Pain Headache Rep       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.